RxDoctor Payments Data

Mary Takaishi, PA

Physician Assistant · Abilene, KSNPI 1841201654

Payments from drug & device makers

$266in general payments, 2019–2025

Across 17 payments — averaging $15.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$47
  • Insulet Corporation$46
  • AbbVie$31
  • Bayer$31
  • Novo Nordisk$29
  • Lilly USA, LLC$23
  • plus $58 from 4 others

What the payments were for

  • Food & beverage$266100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$266 in reported general payments places this provider in the 50th percentile of 1,016 physician assistant providers in Kansas.

See all physician assistant providers in Kansas

Medicare billing

Part B allowed, 2024
$63,334
Medicare patients
291
Services billed
1,177

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide59$62,853
EliquisApixaban55$37,073
OzempicSemaglutide33$31,463
Tresiba Flextouch U-100Insulin Degludec50$21,385
Tresiba Flextouch U-200Insulin Degludec11$20,298
JanuviaSitagliptin Phosphate19$18,028
XareltoRivaroxaban21$12,761
MyrbetriqMirabegron36$12,390
TrulicityDulaglutide12$11,797
FarxigaDapagliflozin Propanediol26$7,550
Spiriva RespimatTiotropium Bromide12$5,953
Rasagiline Mesylate12$5,807
Linezolid11$4,792
NovologInsulin Aspart14$3,971
Dexlansoprazole DrDexlansoprazole14$3,907

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$23$74,65071 claims
Novo NordiskOzempic, Novolog$29$35,43347 claims
AbbVieSynthroid$31$1,05720 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,016 physician assistant providers in Kansas.

Other physician assistant in Abilene

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →